T057: Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume

Detalles Bibliográficos
Autores principales: Lynch, Ryan C., Alig, Stefan, Ujjani, Chaitra S., Poh, Christina, Warren, Edus H., Smith, Stephen D., Shadman, Mazyar, Shustov, Andrei, Till, Brian, Raghunathan, Vikram M., Tseng, Yolanda, Coye, Hilary, Shelby, Megan, Ottemiller, Susan, Keo, Sarith, Verni, Kaitlin, Du, Hongyan, Vandermeer, Jackie, Gaston, Ashley, Rasmussen, Heather, Gulhane, Avanti, Chen, Delphine L., Martin, Paul, Marzbani, Edmond, Voutsinas, Jenna, Alizadeh, Ash A., Gopal, Ajay K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621540/
http://dx.doi.org/10.1097/01.HS9.0000890796.34979.cc

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621540/
http://dx.doi.org/10.1097/01.HS9.0000890796.34979.cc

Ejemplares similares